About Dr. Anil Kumar
Dr. Anil Kumar is a highly respected and leading Medical Oncologist in India. With over 14 years of clinical and academic experience, Dr. Kumar is renowned for his expertise in treating complex solid tumours and hematological malignancies (blood cancers). A distinguished alumnus of the prestigious PGIMER, Chandigarh, and Kidwai Cancer Institute, he combines deep theoretical knowledge with advanced clinical skills. Dr. Kumar has a special interest in medical research, particularly in the fields of Immunotherapy and Targeted Therapy. He has been actively involved in multi-national clinical trials, including studies on HER2-positive breast cancer. His patient-centric approach, combined with his role as a researcher, ensures that his patients receive the most up-to-date, evidence-based cancer care available.
Qualifications & Credentials
- MBBS: Bangalore Medical College, Bengaluru (2005)
- MD (Internal Medicine): Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh (2009)
- DM (Medical Oncology): Kidwai Cancer Institute, Bengaluru (2013)
- Specialised training in Hematology and Solid Tumour Oncology at Kidwai Cancer Institute.
- Advanced training in Clinical Trials and Research Methodology.
- Certified in the administration of Biologicals and Monoclonal Antibodies.
Areas of Expertise
Major Cancer Types Treated
- Breast Cancer (HER2 Positive, Triple Negative)
- Lung Cancer (NSCLC, SCLC)
- Stomach Cancer
- Colon Cancer
- Pancreas Cancer
- Leukemia
- Lymphoma
- Myeloma
- Head and Neck Cancers
Sub-specialties
- Medical Oncology
- Clinical Hematology
- Immunotherapy
- Targeted Therapy & Precision Medicine
- Management of Febrile Neutropenia
Advanced Procedures Performed
- Chemotherapy Administration (Daycare & Inpatient)
- Biological & Monoclonal Antibody Therapy
- Bone Marrow Aspiration and Biopsy
- Intrathecal Chemotherapy
- Management of Chemotherapy Complications
List of Disease and Treatment for which Dr. Anil Kumar can be consulted
Professional Experience
Current & Past Hospital Affiliations
Current Affiliation:
- Senior Consultant, Medical Oncology & Hematology: SPARSH Hospital, Yeshwantpur & Yelahanka, Bengaluru (Since Oct 2019).
Past Affiliations:
- Assistant Professor, Medical Oncology: Ramaiah Medical College and Hospital, Bengaluru (Oct 2013 – 2019).
- Registrar, Internal Medicine: Columbia Asia Hospital, Bengaluru (Dec 2009 – July 2010).
Academic & Research Roles
- Active researcher with a focus on innovations in cancer treatment.
- Participant in a Multicenter, randomised, Phase III study comparing Herceptin plus Taxane versus Biosimilar in metastatic breast cancer.
- Author of numerous research papers in national and international medical journals.
Key Achievements & Contributions
- Successfully treated complex cases of Chronic Eosinophilic Leukemia using Imatinib with dramatic responses.
- Documented and published rare cases such as Neurofibromatosis Type I associated with breast cancer in men.
- Played a pivotal role in academic teaching and training of oncology residents during his tenure as Assistant Professor.
Awards & Recognitions
Recognitions & Honors
- Recognised as a key contributor to oncology research in India with over 10 published research papers.
- Acknowledged for excellence in clinical trial execution and data management.
Membership
- American Society of Clinical Oncology (ASCO)
- European Society for Medical Oncology (ESMO)
- Indian Society of Medical and Paediatric Oncology (ISMPO)
Research & Publications
Published Papers in Medical Journals
- Clinical profile and outcome of febrile neutropenic cancer patients in a tertiary care centre – J. Evid. Based Med. Healthcare (2017)
- Epidermal growth factor receptor inhibitors related trichomegaly of eyelashes – Oxford Medical Case Reports (2014)
- Acute interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small-cell lung cancer after crizotinib therapy – Oxford Medical Case Reports (2014)
- FIP1L1-PDGFRA positive chronic eosinophilic leukemia- low burden disease with dramatic response to Imatinib – Turkish Journal of Hematology (2014)
- Neurofibromatosis type I with breast cancer: not only for women! – Hereditary Cancer in Clinical Practice (2014)
- Long term survival of locally advanced carcinoma larynx in an 8-year-old child – Clinical Cancer Investigation Journal (2013)
- Gastric diffuse large B-cell lymphoma presenting as paraneoplastic cerebellar degeneration – Journal of Egyptian National Cancer Institute (2013)
Ongoing Clinical Trials and Participation
- Principal Investigator for various multi-centre Phase III clinical trials.
Patient Success Stories & Testimonials
Notable Cases Handled
- Successfully managed a rare case of an 8-year-old child with advanced carcinoma of the larynx, achieving long-term survival through a tailored multimodal treatment approach.
- Treated a patient with ALK-positive lung cancer who developed interstitial lung disease; Dr. Kumar's prompt diagnosis and management allowed for the continuation of life-saving therapy.
Patient Testimonials
"Dr. Anil Kumar is a gem of a person. When my mother was diagnosed with breast cancer, we were devastated. His calm approach and detailed explanation of the immunotherapy options gave us hope. Today, she is doing very well. He is undoubtedly a top oncologist in Bangalore."– S. Ramesh
"I visited Dr. Kumar for my father's lymphoma treatment. His knowledge of the latest targeted therapies is exceptional. He guided us through every cycle of chemotherapy with great care, managing side effects effectively. We are grateful for his support."– Meera K.
"Coming from Kenya, we were worried about the treatment process in India. Dr. Anil Kumar made us feel at home at SPARSH Hospital. His diagnosis was accurate, and the treatment plan was effective. I highly recommend him to anyone seeking cancer treatment."– David O.
Treatment Approach & Philosophy
Patient-Centred Care
Dr. Anil Kumar believes in a holistic approach to cancer care, treating not just the disease but the patient as a whole. He emphasizes clear communication, ensuring patients understand their diagnosis and treatment options, which empowers them to make informed decisions.
Technology & Innovation
With a strong background in research, Dr. Kumar integrates the latest advancements in Immunotherapy and Targeted Therapy into his practice. He is a strong advocate for Precision Medicine, utilizing genetic profiling to tailor treatments to the specific molecular characteristics of a patient's tumour.
Treatment Costs
The costs below are estimates and may vary based on the specific drug brands, dosage, and duration of treatment required.
Treatment / Procedure | Cost Estimate (INR) | Cost Estimate (USD) |
Chemotherapy (Per Cycle) | ₹15,000 - ₹60,000 | $180 - $720 |
Immunotherapy (Per Cycle) | ₹1,50,000 - ₹3,50,000 | $1,800 - $4,200 |
Targeted Therapy (Monthly) | ₹1,00,000 - ₹2,50,000 | $1,200 - $3,000 |
Bone Marrow Aspiration & Biopsy | ₹15,000 - ₹25,000 | $180 - $300 |
PET CT Scan | ₹15,000 - ₹25,000 | $180 - $300 |
Note: For appointment booking and to get a personalised cost estimate, you can connect with the Cancer Rounds team.
International Patient Assistance
Language Support
The Cancer Rounds team provides professional language interpretation services to ensure that international patients can communicate effectively with Dr. Anil Kumar.
Visa & Travel Assistance
We assist with Medical Visa invitation letters, flight coordination, airport transfers, and accommodation arrangements near the hospital for patients and their caregivers.
Pre-treatment Virtual Consultations
International patients can book a video consultation with Dr. Anil Kumar through Cancer Rounds to review their medical reports and discuss potential treatment plans before travelling to India.


















